Assignee
ICOS CORP
US159 patents
Top patents by PatentIndex Score
US7932260B2Apr 26, 2011
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP221 citations99
US6949535B2Sep 27, 2005
Inhibitors of human phosphatidyl-inositol 3-kinase delta
ICOS CORP172 citations99
US6667300B2Dec 23, 2003
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP174 citations99
US6518277B1Feb 11, 2003
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP272 citations99
US5888809AMar 30, 1999
Hamster EF-1α transcriptional regulatory DNA
ICOS CORP221 citations99
US5859006AJan 12, 1999
Tetracyclic derivatives; process of preparation and use
ICOS CORP208 citations99
US8980901B2Mar 17, 2015
5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP39 citations98
US8586597B2Nov 19, 2013
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP36 citations98
USRE44599ENov 12, 2013
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP44 citations98
US6043252AMar 28, 2000
Carboline derivatives
ICOS CORP90 citations98
US6521619B2Feb 18, 2003
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
ICOS CORP103 citations97
US6143746ANov 7, 2000
Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
ICOS CORP112 citations97
US5985589ANov 16, 1999
Lipid kinase
ICOS CORP171 citations97
US5858753AJan 12, 1999
Lipid kinase
ICOS CORP191 citations97
US9487772B2Nov 8, 2016
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP19 citations96
US8993583B2Mar 31, 2015
5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP22 citations96
US8779131B2Jul 15, 2014
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP30 citations96
US6348602B1Feb 19, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP49 citations96
US6306870B1Oct 23, 2001
N-cinnamoyl derivatives of beta-carboline
ICOS CORP63 citations96
US6140329AOct 31, 2000
Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence
ICOS CORP72 citations96
US5932703AAug 3, 1999
Macrophage derived chemokine and chemokine analogs
ICOS CORP72 citations96
US5880268AMar 9, 1999
Modulators of the interaction between ICAM-R and αd /CD18
ICOS CORP78 citations96
US5869262AFeb 9, 1999
Method for monitoring an inflammatory disease state by detecting circulating ICAM-R
ICOS CORP48 citations96
US5773218AJun 30, 1998
Method to identify compounds which modulate ICAM-related protein interactions
ICOS CORP43 citations96
US6423710B1Jul 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP47 citations95
US5981527ANov 9, 1999
Cyclic GMP-specific phosphodiesterase inhibitors
ICOS CORP68 citations95
US5882910AMar 16, 1999
Lipid kinase
ICOS CORP64 citations95
US5470953ANov 28, 1995
Human β2 integrin α subunit
ICOS CORP47 citations95
US6797811B1Sep 28, 2004
Antibodies to chemokine receptor 88C
ICOS CORP56 citations94
US6268477B1Jul 31, 2001
Chemokine receptor 88-C
ICOS CORP77 citations94
US6265184B1Jul 24, 2001
Polynucleotides encoding chemokine receptor 88C
ICOS CORP75 citations94
US6258833B1Jul 10, 2001
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP55 citations94
US6218400B1Apr 17, 2001
Treatment method using a cGMP-Specific PDE inhibitor
ICOS CORP53 citations94
US5652131AJul 29, 1997
Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods
ICOS CORP34 citations94
US5532152AJul 2, 1996
Platelet-activating factor acetylhydrolase
ICOS CORP39 citations94
US10010550B2Jul 3, 2018
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP11 citations92
US9149477B2Oct 6, 2015
5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP17 citations92
US6784179B2Aug 31, 2004
Tetracyclic derivatives, process of preparation and use
ICOS CORP14 citations92
US6716871B2Apr 6, 2004
Cyclic AMP-specific phosphodie sterase inhibitors
ICOS CORP14 citations92
US6680336B2Jan 20, 2004
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP23 citations92
US6608065B1Aug 19, 2003
Use of cGMP phosphodiesterase inhibitors in methods to treat female sexual dysfunction
ICOS CORP18 citations92
US6500856B2Dec 31, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP20 citations92
US6498015B1Dec 24, 2002
Methods of identifying agents that modulate the binding between MDC and an MDC receptor
ICOS CORP51 citations92
US6486186B2Nov 26, 2002
Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
ICOS CORP43 citations92
US6462047B1Oct 8, 2002
Carboline derivatives as cGMP phosphodiesterase inhibitors
ICOS CORP40 citations92
US6455562B1Sep 24, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP18 citations92
US6444671B1Sep 3, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP16 citations92
US6432404B1Aug 13, 2002
Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies
ICOS CORP38 citations92
US6399571B1Jun 4, 2002
Chitinase chitin-binding fragments
ICOS CORP27 citations92
US6376489B1Apr 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP22 citations92
Showing the top 50 of 159 patents by PatentIndex Score.